Breast Cancer Trials
What happens when a drug is proving to be very effective in a trial?
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:04:49
- Mais informações
Informações:
Sinopse
Associate Professor Nicholas Wilcken was the Study Chair of the HERA clinical trial which tested the drug Herceptin and delivered a major breakthrough for women with HER2 positive breast cancer. In this podcast, Associate Professor Wilcken discusses what happens when a drug is proven effective in a clinical trial. Find out more: www.breastcancertrials.org.au
